These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8804728)

  • 1. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
    Raghupathi RK; Artymyshyn R; McGonigle P
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ.
    Raghupathi RK; Brousseau DA; McGonigle P
    Brain Res Mol Brain Res; 1996 Jun; 38(2):233-42. PubMed ID: 8793111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
    Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
    Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
    Vinod KY; Subhash MN; Srinivas BN
    Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
    Keck BJ; Lakoski JM
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
    Keck BJ; Lakoski JM
    Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.
    Kettle CJ; Cheetham SC; Martin KF; Prow MR; Heal DJ
    Neuropharmacology; 1999 Sep; 38(9):1421-30. PubMed ID: 10471096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
    Keck BJ; Lakoski JM
    Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
    López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
    J Comp Neurol; 2001 Jan; 429(4):571-89. PubMed ID: 11135236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
    Pinto W; Battaglia G
    Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Ni YG; Camacho N; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
    Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
    Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
    Koek W; Assié MB; Zernig G; France CP
    Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional study of rat 5-HT2A receptors using antisense oligonucleotides.
    Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
    J Neurochem; 2003 Jun; 85(5):1087-100. PubMed ID: 12753068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.